Finance
Tilray stock surges after exporting cannabis treatment to Australia
Tilray, one of the largest Canadian marijuana companies, said Tuesday that it had successfully shipped a CBD product to Australia for treatment of children with epilepsy at three hospitals in Victoria. CBD is one of the nonpsychoactive compounds found in cannabis.
The company’s stock surged 17% following the announcement, breaking a three-day losing streak for the $8.7 billion company.
It’s the second round of medical cannabis exporting by Tilray to the Australian state under the government’s “compassionate access” scheme, which first treated 29 critically-ill patients in March 2017. The patients were the first in Victoria to legally access marijuana-derived medicines.
Similar export announcements by Tilray last week — involving treatment of Essential Tremor (ET) in California — also sparked a rally in shares, before falling 53% from their September 19 high of more than $119 apiece. Wall Street remains concerned abut stretched valuations following the stock’s more than 500% surge since its July initial public offering, giving it an average price target of $62 — implying a possible drop of 57%.
One prominent short-seller, Andrew Left of Citron Research, compared the rally in cannabis names to the cryptocurrency craze of early 2018: “These stock prices are equivalent to bitcoin mania – although it is even more ridiculous than bitcoin,” he said on September 12, when Tilray shares were trading even lower than where they were on Tuesday.
-
Business6 days ago
Tesla’s new growth plan is centered around mysterious cheaper models
-
Business5 days ago
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs
-
Business6 days ago
UK probes Amazon and Microsoft over AI partnerships with Mistral, Anthropic, and Inflection
-
Entertainment4 days ago
Summer Movie Preview: From ‘Alien’ and ‘Furiosa’ to ‘Deadpool and Wolverine’
-
Business5 days ago
Petlibro’s new smart refrigerated wet food feeder is what your cat deserves
-
Business3 days ago
How Rubrik’s IPO paid off big for Greylock VC Asheem Chandna
-
Entertainment3 days ago
What’s on the far side of the moon? Not darkness.
-
Business4 days ago
Thoma Bravo to take UK cybersecurity company Darktrace private in $5B deal